Compare HUMA & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUMA | ISPR |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 175.8M |
| IPO Year | N/A | 2023 |
| Metric | HUMA | ISPR |
|---|---|---|
| Price | $1.01 | $3.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $10.00 | $7.50 |
| AVG Volume (30 Days) | ★ 6.1M | 63.5K |
| Earning Date | 03-27-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,571,000.00 | ★ $96,965,571.00 |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | $731.05 | $40.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.88 | $1.44 |
| 52 Week High | $4.14 | $4.98 |
| Indicator | HUMA | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 46.36 | 53.67 |
| Support Level | $0.96 | $2.98 |
| Resistance Level | $1.03 | $3.68 |
| Average True Range (ATR) | 0.10 | 0.34 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 27.76 | 38.95 |
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.